>I was intrigued with the description of the "patient finding" mechanism required and surprised that it might only require a dozen sales specialists.<
A dozen sales specialists are a pretty big expense at the going rate for reps these day. GTC should (and IMO, will) stick to its knitting: drug manufacturing and development. Let someone else do the selling.
“The efficient-market hypothesis may be the foremost piece of B.S. ever promulgated in any area of human knowledge!”